ArticleReproductive health2025
Family planning and abortion service availability and utilisation during the COVID-19 pandemic in Ghana.
Article in Reproductive health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Responding to the COVID-19 pandemic through global partnerships: the case of the HRP Alliance for research capacity strengthening.Reproductive health · 2026Article
- Pandemic lessons: protecting sexual and reproductive health during global health emergencies.Reproductive health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe effect of COVID-19 has manifested both in the capacity of healthcare systems to provide services as well as create a good balance between pandemic management and maintenance of essential health services. Earlier studies in Ghana during the pandemic reported low patronage of family planning (FP) services but a sudden spike in emergency contraceptive pill utilization. This paper seeks to assess health service availability and readiness, client needs for, and utilization of FP and abortion services during the COVID-19 pandemic period in Ghana.
methodsThis study was a panel study with two-time data collection points six to nine months apart. Both quantitative and qualitative approaches were used. A one-time survey was used to assess SRH service utilization by 997 clients. Qualitative data involved a total of 24 Focus Group Discussions (FGDs), 128 In-depth Interviews (IDIs) with female clients and their male partners, and 32 IDIs with healthcare practitioners in the four selected facilities. Also, the WHO Service Availability, Readiness and Assessment tool was completed for the health facilities at baseline and endline. Descriptive statistics and thematic analysis were conducted for quantitative and qualitative data respectively.
resultsAge of clients and their male partners participating in IDIs ranged between 18 and 50 years (mean = 33.2 years) while participants for community FGDs ranged between 16 and 56 years (mean = 32.0 years). The majority (68%) of clients visiting the health facility for SRH care sought FP services while 5% sought abortion/post-abortion care of which 71% needed post-abortion care. Attendance data showed sensitivity to the occurrence of the different waves of COVID-19. Family planning and abortion services were generally available but witnessed some short-lived disruption. Healthcare managers reported financial stress which led to innovations in procurement of PPEs and hand sanitizers. Telemedicine facilities did not provide SRH care. Fear of stigma was a major barrier to access to abortion care.
conclusionThe relatively low COVID-19 infection rates in Ghana preceded by the national COVID-19 preparedness strategy may explain the low impact on disruption of FP and abortion services. Development of SRH specific guidelines and strengthening telemedicine facilities to include SRH care may reduce future disruption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.